HealthTronics Inc. reported consolidated unaudited earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported revenue from continuing operations totaled $47.3 million, up from $44.8 million in the third quarter of 2008. The company's net loss for the third quarter of 2009, in accordance with GAAP totaled $2.3 million or $0.06 per diluted share. The company's non-GAAP net income, which excludes stock based compensation and costs related to the Endocare transaction, totaled $0.05 per share in the quarter. This compares to non-GAAP net income of $0.04 per share in the third quarter of 2008. The company's adjusted EBITDA from continuing operations for the third quarter of 2009 was $7.1 million, which compares to $6.2 million in the third quarter of 2008. Net debt was $37,873,000 as compared to negative net debt of $6,322,000 for the same period last year. EBITDA was $21,555,000 as compared to $21,782,000 for the same period last year. Capital expenditures was $1,286,000 as compared to $3,147,000 for the same period last year. Non-GAAP net income was $1,874,000 as compared to $1,399,000 for the same period last year. Cash provided by operating activities was $9,884 for the third quarter of 2009. For nine months, the company reported operating income of $42,717,000, income from operations before provision for income taxes of $1,967,000, net income of $39,958,000, net loss attributable to company of $1,583,000 or $0.04 per share on revenue of $135,051,000 as compared to operating income of $44,092,000, income from operations before provision for income taxes of $1,730,000, net income of $42,869,000, net income attributable to company of $2,489,000 or $0.07 per share on revenue of $121,305,000 for the same period last year. Net debt was $37,873,000 as compared to negative net debt of $6,322,000 for the same period last year. Adjusted EBITDA was $18,084,000 as compared to $16,210,000 for the same period last year. EBITDA was $59,625,000 as compared to $56,590,000 for the same period last year. Capital expenditures was $5,712,000 as compared to $8,762,000 for the same period last year. The board of directors has appointed Richard Rusk to Chief Financial Officer. Richard joined HealthTronics in August 2000 as Corporate Controller and has been serving as Interim Chief Financial Officer since September 2008.

HealthTronics Inc., Q3 2009 Earnings Call, Nov-05 2009

HealthTronics Inc. expected to Report Fiscal Year 2009 Results on March 1, 2010. This event was calculated by Capital IQ (Created on October 22, 2009).